About "PK repeats" [Software]

posted by Helmut Homepage – Vienna, Austria, 2010-10-21 19:01 (5314 d 08:13 ago) – Posting: # 6072
Views: 15,941

Dear Ohlbe!

❝ ❝ Following the presentation, a comment was brought forth stating that regulatory agencies recommend against performing PK repeats


❝ Unfortunately. But remember the discussions at the EBF/EUFEPS meeting in Brussels in April: on the European side there is still some hope that the ban will be restricted to BE trials only, not to other PK trials. And there is still a possibility in the draft for repeats for lab investigations. So we are not completely loosing our time.


Yes, I remember. ;-)
But I must confess that I don't see the rationale behind 'a ban on BE studies'. Much more is know about the PK of the drug at that stage as compared to FIM or PK-studies of the innovator...

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
145 visitors (0 registered, 145 guests [including 11 identified bots]).
Forum time: 03:15 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5